BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15660582)

  • 1. Novel approaches in an integrated therapy of inflammatory-associated wasting in end-stage renal disease.
    Stenvinkel P; Lindholm B; Heimbürger O
    Semin Dial; 2004; 17(6):505-15. PubMed ID: 15660582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone mineral density in end-stage renal disease patients: association with wasting, cardiovascular disease and mortality.
    Matsubara K; Suliman ME; Qureshi AR; Axelsson J; Martola L; Heimbürger O; Barany P; Stenvinkel P; Lindholm B
    Blood Purif; 2008; 26(3):284-90. PubMed ID: 18421213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation and oxidative stress in ESRD--the role of myeloperoxidase.
    Maruyama Y; Lindholm B; Stenvinkel P
    J Nephrol; 2004; 17 Suppl 8():S72-6. PubMed ID: 15599890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic inflammation and cardiovascular risk in hemodialysis].
    Pertosa G; Simone S; Soccio M; Marrone D; Grandaliano G
    G Ital Nefrol; 2003; 20(6):631-40. PubMed ID: 14732917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease.
    Yao Q; Pecoits-Filho R; Lindholm B; Stenvinkel P
    Scand J Urol Nephrol; 2004; 38(5):405-16. PubMed ID: 15764253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malnutrition and wasting in renal disease.
    Muscaritoli M; Molfino A; Bollea MR; Rossi Fanelli F
    Curr Opin Clin Nutr Metab Care; 2009 Jul; 12(4):378-83. PubMed ID: 19474712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Malnutrition -- inflammation -- atherosclerosis (MIA syndrome) in patients with renal failure].
    Pawlaczyk K; Oko A; Lindholm B; Czekalski S
    Pol Merkur Lekarski; 2003 Oct; 15(88):334-41; discussion 341-3. PubMed ID: 14974361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of inflammation to vascular disease in chronic kidney disease patients.
    Suliman ME; Stenvinkel P
    Saudi J Kidney Dis Transpl; 2008 May; 19(3):329-45. PubMed ID: 18445891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation as a cause of malnutrition, atherosclerotic cardiovascular disease, and poor outcome in hemodialysis patients.
    Yao Q; Lindholm B; Stenvinkel P
    Hemodial Int; 2004 Apr; 8(2):118-29. PubMed ID: 19379407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of interleukin-1beta in the development of malnutrition in chronic renal failure patients.
    Maruyama Y; Stenvinkel P; Lindholm B
    Blood Purif; 2005; 23(4):275-81. PubMed ID: 15925866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of inflammation and nutrition in patients with end-stage renal disease.
    Don BR; Kaysen GA
    J Nephrol; 2000; 13(4):249-59. PubMed ID: 10946803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory proteins as predictors of cardiovascular disease in patients with end-stage renal disease.
    Zoccali C; Mallamaci F; Tripepi G
    Nephrol Dial Transplant; 2004 Aug; 19 Suppl 5():V67-72. PubMed ID: 15284363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF; McCarthy M; Howse ML; Williams PS
    Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation in end-stage renal disease: the hidden enemy.
    Stenvinkel P
    Nephrology (Carlton); 2006 Feb; 11(1):36-41. PubMed ID: 16509930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of diabetes mellitus on protein-energy wasting and protein wasting in end-stage renal disease.
    Noori N; Kopple JD
    Semin Dial; 2010; 23(2):178-84. PubMed ID: 20525107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on inflammation in chronic kidney disease.
    Akchurin OM; Kaskel F
    Blood Purif; 2015; 39(1-3):84-92. PubMed ID: 25662331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. End-stage renal disease--not an equal opportunity disease: the role of genetic polymorphisms.
    Nordfors L; Lindholm B; Stenvinkel P
    J Intern Med; 2005 Jul; 258(1):1-12. PubMed ID: 15953127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation.
    Suliman M; Stenvinkel P; Qureshi AR; Kalantar-Zadeh K; Bárány P; Heimbürger O; Vonesh EF; Lindholm B
    Nephrol Dial Transplant; 2007 Jan; 22(1):209-17. PubMed ID: 16982634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutrition, inflammation and chronic kidney disease.
    Ikizler TA
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):162-7. PubMed ID: 18277149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients.
    de Mutsert R; Grootendorst DC; Axelsson J; Boeschoten EW; Krediet RT; Dekker FW;
    Nephrol Dial Transplant; 2008 Sep; 23(9):2957-64. PubMed ID: 18400817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.